Arpa Garay

Companies

• ModernaChief Commercial Officer Jun 29, 2022 to Dec 7, 2023¹
• Merck & Co.SVP Human Health Global Mktg. Mar 10, 2022 to May 5, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Moderna MRNA3,690 shares³$836.4K at $226.67Dec 6, 2023
• Merck & Co. MRK2,109 shares⁴$307.6K at $145.87May 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 6, 2023Sold 564 shares at $78.34 of Moderna³
• Dec 5, 2023Exercised options 1,141 shares of Moderna³
• Sep 6, 2023Sold 574 shares at $108.40 of Moderna⁵
• Sep 5, 2023Exercised options 1,140 shares of Moderna⁵
• Jun 6, 2023Sold 2,290 shares at $125.75 of Moderna⁶
• Jun 5, 2023Exercised options 4,562 shares of Moderna⁶
• May 4, 2022Shares withheld for tax 259 shares at $87.10 of Merck & Co.⁴
• May 4, 2022Exercised options 907 shares at $87.10 of Merck & Co.⁴
• May 3, 2022Shares withheld for tax 221 shares at $87.65 of Merck & Co.⁷
• May 3, 2022Exercised options 773 shares at $87.65 of Merck & Co.⁷
• May 1, 2022Shares withheld for tax 247 shares at $88.69 of Merck & Co.⁸
• May 1, 2022Exercised options 866 shares at $88.69 of Merck & Co.⁸